Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

Delayed Quote. Delayed BATS Europe - 08/31 11:29:59 am
94.55 CHF   +0.37%
11:05aDJGoogle, Sanofi Team Up on Diabetes Research
10:42a NOVARTIS : BioCamp highlights how collaboration and diversity drive ..
10:35a Google, Sanofi team up to improve diabetes care
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
08/25/2015 08/26/2015 08/27/2015 08/28/2015 08/31/2015 Date
92.65(c) 90.65(c) 94.35(c) 94.2(c) 94.7 Last
9 747 473 8 183 106 6 051 811 5 461 230 4 598 303 Volume
+3.40% -2.16% +4.08% -0.16% +0.53% Change
More quotes
Financials ($)
Sales 2015 51 544 M
EBIT 2015 14 318 M
Net income 2015 12 256 M
Debt 2015 6 686 M
Yield 2015 2,90%
Sales 2016 52 664 M
EBIT 2016 13 803 M
Net income 2016 10 458 M
Debt 2016 4 770 M
Yield 2016 3,07%
PER 2015 16,79
PER 2016 22,22
EV / Sales 2015 5,19x
EV / Sales 2016 5,05x
Capitalization 261 048 M
More Financials
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers... 
Sector
Pharmaceuticals
Calendar
09/17Presentation
More about the company
Surperformance© ratings of Novartis AG
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVARTIS AG
04:07p VALNEVA Reports Strong H1 2015 Revenues
01:20p NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
11:05aDJGoogle, Sanofi Team Up on Diabetes Research
10:42a NOVARTIS : BioCamp highlights how collaboration and diversity drive innovation a..
10:35a Google, Sanofi team up to improve diabetes care
09:15aDJGoogle, Sanofi Join Forces on Diabetes Monitoring, Treatment
08/28 NOVARTIS INDIA : To sell otc unit to gsk
08/28 NOVARTIS : continues commitment to go the last mile in effort to eliminate lepro..
More news
Sector news : Pharmaceuticals - NEC
05:13p Chipotle sued over GMO-free menu claims
03:50p BIOGEN : ALERT: Rosen Law Firm Reminds Biogen Inc. Investors of Important Deadli..
11:05aDJGoogle, Sanofi Team Up on Diabetes Research
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
04:25p BIOTECH REVIEW (PART 2 OF 3) : New Coverage Of Some Mid-Caps With Update On Inte..
10:07a Closed-End Funds Trading At A Discount To NAV
08/28 Why Anavex Is Leading The Race Against Other Pharma To Help Alzheimer's Patie..
08/27 TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial
08/27 PREMARKET BIOTECH DIGEST : CLL Treatment, Gilead CEO Sells, Acelity IPO


Comments 
Advertisement
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions